Izazivanje model-oboljenja i ispitivanje konzekutivnih promjena serotonina i monoaminooksidaze u raznim tkivima

Authors

  • Seid Huković

DOI:

https://doi.org/10.5644/Radovi.160

Abstract

No abstract available.

References

Akcasu A., Akcasu M. and Tumay S. B.: Nature 187, 324, 1960. cit. Garattini, S., Valzelli, L. »Serotonin«, Elsevier Publ. Comp., Am­sterdam, London, New York, 1965.

Amin A. H., Crawford T. B. B. and Gaddum J. H.: The distribution of substance P and 5-hydroxytryptamine in the centra! nervous system of the dog. J. Physiol. 127, 596, 1954.

Aprison M. H.: Recent Advances in Biological Psychiatry, Grune and Stration, New York, 1962, p. 4.

Arnaud P h., Arnaud J. L., Loisy Cl. ct J. Kofman: Serotonine et glandes endocrines. In.: "Serotonine et pathologie digestive" Symposium de Vichy, Septembre 1968. Compagnie Fermiere de Vichy, p. 157.

Baciocchi M., Grandmontagne O. and Rouaux J.: Gaz. med. France, 1545, 1961. Cit. Garattini, S. and Valzelli, L. "Serotonin", Elsevier Publ. Comp. Amsterdam, London, New York, 1965.

Bel A.: Serotonin and Dumping syndrome. In: Serotonine et pathologie digestive, Symposium de Vichy, Septembre, 1968, p. 233.

Bedill E. P.: 5-hydroxytryptamine and 5-hydroxytryptophan decarboxylase in rat mast cells. In: Levvis, G. P. "5-Hydroxytryptamine", Pergamon Press, New York, London, Pariš, 1958, 32.

Blaschko H.: Amine oxidase and amine metabolism. Pharmac. Rev. 4, 415—458, 1952.

Biilbring E.: The intrinsic nervous system of the intestine and local effects of 5-Hydroxytryptamine. In: Regional neurochemistry. Edit. Kety, S. S. and Elkes, J., Pergamon Press, Oxford, 1961, 437—441.

Biilbring E. and Gershon M. D.: Serotonin participation in the vagal inhibitory pathway to the stomach. Adv. Pharmac. 6 A, 323—333, 1968.

Burn J. H., Finney D. J. e Bagnulo R.: Nuove indagini in tema di tossicosi aminiche in schizofrenici. Acta Neurol. 10, 547, 1955.

Chessin M., Kramer E. R. and Scott C. C.: Modification of the pharmacology of reserpine and serotonin by iproniazid. J. Pharmacol. Therapuet. 119, 453, 1957.

Colobert L., Arnaud J. L. et Arnaud Ph.: Les processus d’elimination de la serotonine dans l’organisme humain. In: "Serotonine et pathologie digestive" Symposium de Vichy, September, 1968, Com­pagnie Fermiere de Vichy, 37.

Cotzias G. C. and Deple V. P.: Metabolism of amines. Microdetermination of MOO in tissues. J. Biol. Chem. 190, 665, 1951.

Cuvelier B., Arnaud J. L., Auble t-Cuvelier J., Aublet-Cuvelier A. M.: Responsability of serotonin in the development of allergic phenomenom. In: "Serotonine et pathologie digestive" Symposium de Vichy, September, 1968, Compagnie Fermiere de Vichy, p. 123.

Dalgiesh C. E., Toh C. C. and Work T. S.: Smooth muscle stimulants from the gastrointestinal tract. Identification of 5-hydroxytryptamine and its distinction from substance P. Biochem. J. 52, 30, 1952.

Douglas W. W.: Histamine and antihistamines, 5-hydroxytryptamine and antagonists. In: Goodman, L. S. and Gilman, A. "The pharmacological basis of therapeutics" The Macmillan Comp. London, Toronto,

1970, p. 621.

Dunn J. S., Sheehan, H. L. and McLetchin, N. G. B.: Necrosis of islets of Langerhans produced experimentally. Lancet, 1, 484, 1943.

Erspamer V.: Richerche farmacologiche sull’enteramina. VII. Enteramina e indolalchilamine del veleno di rospo. Acho Sci. Biol. 31, 86—95, 1946.

Ersp amer V.: II sistema cellulare enterocromafine e l'enteramina (5 idrossi triptamina). Rendiconti Scient. Farmitalia 1, 1, 1954.

Erspamer V.: Observation on the fate of exogenous 5-hydroxytryptamine (enteramin) in the rat. J. Physiol. 127, 113. 1955.

Feyerter F.: Uber diffuse Endokrine Epitheliale Organ. Tag d. Nord und osteutchen Pathologen Dresden, 19, 12, 1938.

Fishel C. W. and Szentivanyi A.: An The absence of epinephrine induced hyperglycemia in pcrtussis-sensitized mice. Federation Proc. 21, 270, 1962.

Fischer R. A.: Metodi statistici ad uso dei ricercatori. U. T. E. T. Torine, 1948.

Gaddum J. H. and Hameed K. A.: Drugs vvhich antagonize 5-hydroxytryptamine. Brit. J. Pharmacol. 9, 240—248, 1954.

Gaddum J. H. and Picarelli Z. P.: Two kinds of tryptamine receptor. Brit. J. Pharmacol. 12, 323, 1957.

Garattini S. and Valzelli L.: "Serotonin", Elsevier Publ. Comp., Amsterdam, London, 1965.

Gillette J. R.: Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. In: Garattini, S. and Shore, P. A. "Advances in Pharmacology" 4, 219—261, Academic Press, Ine. New York, 1966.

Hamalin K. E. and Fischer F. E.: The synthesis of 5-hydroxytryptamine. J. Am. Cjem. Soc. 73, 5007—5008, 1951.

Huković S. and Hallasmoller T.: The aplication effect of se­rotonin and other drugs on the mucous and serous membrane owing to the responses of the isolated stomach to electrical nerve stimulation. Folia Medica Facultatis Medicinae Universitatis Saraeviensis 6, 115——125, 1971.

Huković S.: Količina 5-hidroksitriptamina i aktivitet monoaminooksidaze u raznim procesima, mozga, jetre, bubrega i crijeva. Disertacija, Sarajevo, 1958.

Ivy A. C., Goetzl F. R., Harris S. C. and Burrill D. Y.: The analgesic effect of intracarotid and intravenous injeetion of epinephrine in dogs and of subcutaneous injeetion in man. Q. Buli. N. West. Univ. med. Sch. 18, 298—306, 1944.

Innes I. R. and Nickerson M.: Drugs acting on postganglionic adrenergic nerve endings and struetures innervated by them (sympathomimetic drugs). In: Goodman, L. W. and Gilman, A. "The pharmacological basis of therapeutics" The Macmillan Comp. London, To­ronto, 1970, p. 478.

Jouvet M. et Pujol J. F.: Role de la serotonine dans la regulation de quelques systemes de neurones centraux. In: "Serotonine et pathologie digestive", Symposium de Vichy, Septembre 1968, Compagnie Fermiere de Vichy, p. 75.

Jouvet M.: Insomnia and decrease of cerebral 5-hydroxytryptamine after destruetion of the raphe system in the cat. Adv. Pharmacol. 6B, 265—279, 1968.

Karki N. T., Kuntzman R. and BrodieB. B.: Federation Proc. 19, 184, 1960.

Krnjević H.: Protektivno i kurativno djelovanje malih doza reserpina na eksperimentalni čir želuca kod štakora. Disertacija, Zagreb, 1971.

Lecomte J., Franchimont P.: Sur quelques action vasculaires de la 5-Hydroxytryptamine. In: "Serotonine et pathologie digestive" Symposium de Vichy, Septembre 1968, Compagnie Fermiere de Vichy, p. 135.

Pages A.: Serotonin and carcinoids. In: Serotonine et pathologie dige­stive Symposium de Vichy, Septembre 1968, Compagnie Fermiere de Vichy, p. 187.

Pare C. M. B., Sandler M. and Stacey R. S.: Lancet, 1, 551, 1957.

Pineda A., and Snyder R. S.: Neurology 13, 166, 1956.

Rand M. J. and Trinker F. R.: The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors. Brit. J. Pharmac. Chemother. 33, 287— 303, 1968.

Raport M. M., Green A. A. and I. H.: Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J. Biol. Chem. 176, 1243—1251, 1948.

Rapport M. M.: Serum vasoconstrictor (serotonin). V. The presence of creatinine in the complex: a proposed study of the vasoconstrictor principle. J. Biol. Chem. 180, 961—969, 1949.

Scoll K. G., Scheline R. R. and Stone R. S.: Cancer Research, 18, 927, 1958.

Sjoerdsma A., Smith T. E., Stefenson T. D. and Udenfriend S.: Am. J. Med. 20, 520, 1956.

Stacey R. S.: Red cells and 5-hydroxytryptamine. J. Physiol. 132, 39P, 1956.

Udenfriend S.: Metabolism of 5-hydroxytryptamine. In: Lewis, G. P. "5-Hydroxytryptamine" Pergamon Press, New York, London, 1958, p. 43.

Vane J. R.: A sensitive method for the assay of 5-hydroxytryptamin. Brit. J. Pharmacol. 12, 344, 1957.

Valzelli L. et Garattinin S.: Acquisitions recentes dans le domaine de la biosynthese de la serotonine. In: »Serotonine et pathologie digestive Symposium de Vichy, Compagnie Fermiere de Vichy, 1968, p. 27.

Vaughan M.: Biol. Chem. 235, 3049, 1960.

Verdesca A. S., Westermann C. D., Crampton R. S., Black W. C., Nedeljković R. I. and Hi 1 ton J. G.: Am J. Physiol. 201, 1965, 1961.

Way E. L., Loh H. H. and Shen F.: Morphine tolerance, physical dependence, and synthesis of brain 5-hydroxytryptamine. Science N. Y., 162, 1290—1292, 1968.

Wooley D. W., Shaw E.: An biochemical and pharmacological sugestion about certain mental disorders. Proc. National Acad. Sci. 40, 228, 1954.

Published

02.07.1972

Issue

Section

Works

How to Cite

Izazivanje model-oboljenja i ispitivanje konzekutivnih promjena serotonina i monoaminooksidaze u raznim tkivima. (1972). Acta Medica Academica, 16, 137-159. https://doi.org/10.5644/Radovi.160

Most read articles by the same author(s)